Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA PANACEA BIOTECH ELDER PHARMA/
PANACEA BIOTECH
 
P/E (TTM) x -1.0 -60.9 - View Chart
P/BV x 0.1 0.9 11.5% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ELDER PHARMA   PANACEA BIOTECH
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
PANACEA BIOTECH
Mar-23
ELDER PHARMA/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs380191 198.6%   
Low Rs188107 175.5%   
Sales per share (Unadj.) Rs489.275.1 651.4%  
Earnings per share (Unadj.) Rs-3.2-5.5 57.7%  
Cash flow per share (Unadj.) Rs14.40.9 1,641.0%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs376.5137.7 273.4%  
Shares outstanding (eoy) m20.5461.25 33.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.62.0 29.2%   
Avg P/E ratio x-89.3-27.1 329.7%  
P/CF ratio (eoy) x19.7170.0 11.6%  
Price / Book Value ratio x0.81.1 69.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,8329,142 63.8%   
No. of employees `000NANA-   
Total wages/salary Rs m2,1791,265 172.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,0484,599 218.5%  
Other income Rs m257517 49.7%   
Total revenues Rs m10,3055,116 201.4%   
Gross profit Rs m2,92147 6,211.9%  
Depreciation Rs m361391 92.3%   
Interest Rs m2,75644 6,212.1%   
Profit before tax Rs m60128 46.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m125466 26.9%   
Profit after tax Rs m-65-337 19.4%  
Gross profit margin %29.11.0 2,843.5%  
Effective tax rate %209.1363.5 57.5%   
Net profit margin %-0.6-7.3 8.9%  
BALANCE SHEET DATA
Current assets Rs m9,2405,623 164.3%   
Current liabilities Rs m9,9983,297 303.2%   
Net working cap to sales %-7.550.6 -14.9%  
Current ratio x0.91.7 54.2%  
Inventory Days Days12859 218.5%  
Debtors Days Days60248 1,262.0%  
Net fixed assets Rs m13,6427,028 194.1%   
Share capital Rs m20661 335.8%   
"Free" reserves Rs m7,5288,375 89.9%   
Net worth Rs m7,7338,436 91.7%   
Long term debt Rs m4,889202 2,424.6%   
Total assets Rs m22,88212,712 180.0%  
Interest coverage x1.03.9 26.3%   
Debt to equity ratio x0.60 2,644.9%  
Sales to assets ratio x0.40.4 121.4%   
Return on assets %11.8-2.3 -510.1%  
Return on equity %-0.8-4.0 21.1%  
Return on capital %22.32.0 1,117.7%  
Exports to sales %3.143.3 7.0%   
Imports to sales %0.424.4 1.8%   
Exports (fob) Rs m3071,992 15.4%   
Imports (cif) Rs m431,124 3.8%   
Fx inflow Rs m3071,992 15.4%   
Fx outflow Rs m1251,191 10.5%   
Net fx Rs m181801 22.6%   
CASH FLOW
From Operations Rs m11,754-4,225 -278.2%  
From Investments Rs m-5614,303 -13.0%  
From Financial Activity Rs m-6,762-184 3,680.3%  
Net Cashflow Rs m5,466-105 -5,206.8%  

Share Holding

Indian Promoters % 25.3 73.6 34.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 24.0 1.0 2,524.2%  
FIIs % 0.0 0.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 74.7 26.4 282.7%  
Shareholders   31,548 47,091 67.0%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Elder Pharma vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Elder Pharma vs Panacea Biotech Share Price Performance

Period Elder Pharma Panacea Biotech S&P BSE HEALTHCARE
1-Day 4.97% -1.74% 1.18%
1-Month 21.21% -20.01% -0.75%
1-Year -64.54% 11.75% 61.82%
3-Year CAGR -51.65% -12.26% 18.16%
5-Year CAGR -37.46% -9.98% 19.79%

* Compound Annual Growth Rate

Here are more details on the Elder Pharma share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of Elder Pharma hold a 25.3% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Elder Pharma and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, Elder Pharma paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Elder Pharma, and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.